It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
INTRODUCTION: The Ukrainian State Scientific-Research Institute of Nanobiotechnology and Resources Saving has received nanochromium citrate (NCC), a new chrome compound, by means of the electric pulse aquananotechnology method.
OBJECTIVES: to determine nanochromium citrate efficacy with experimental dexamethasone-induced diabetes through the results of antihyperglycemic activity and its effect on the pancreatic histological structure.
METHODS: diabetes mellitus was simulated by dexamethasone administration on 18-month male rats. The morphological structure of the pancreas was examined in comparison with metformin. Examination of the pancreas morphological structure considered the amount, distribution and size of the pancreatic islets and their cellular shape.
RESULTS: on the 14th day of simulated diabetes mellitus the preventitive -therapeutic indication of nanochromium citrate promoted a decrease of glycemia level twice. The administration of nanochromium citrate with underlying diabetes mellitus is not inferior to metformin and its protective effect on the pancreas morphological structure exceeds the effect of metformin.
CONCLUSION: nanochromium citrate of experimental dexamethasone-induced diabetes mellitus in rats decreases the glycemia level twice which does not differ reliably from the effect of metformin antihyperglycemic. The cytoprotective effect of nanochromium citrate produced on the histological structure of the pancreas is found to exceed metformin action.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer